Open AccessA Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma
Author(s) -
Anita D’Souza,
Nina Shah,
Cesar Rodriguez,
Peter M. Voorhees,
Katja Weisel,
Orlando F. Bueno,
Rajvineeth Kumar Pothacamury,
Kevin J. Freise,
Susan Yue,
Rodrigue S. Allodji,
Akshanth R. Polepally,
Chetasi Talati,
Shane Lee,
Ziyi Jin,
Ben Buelow,
Ravi Vij,
Shaji Kumar
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.01504
Subject(s) - medicine , neutropenia , adverse effect , cytokine release syndrome , refractory (planetary science) , gastroenterology , multiple myeloma , febrile neutropenia , surgery , toxicity , immunotherapy , cancer , physics , chimeric antigen receptor , astrobiology